EP0293090A2 — Surgically implantable laminated plastics materials and processes for their production
Assigned to Baxter International Inc · Expires 1988-11-30 · 37y expired
What this patent protects
The present invention provides porous biologically compatible materials capable of being formed into surgical implants, comprising layers of poly(tetrafluoroethylene) and elastomer, having superior compliance, strength, elasticity and suturability. The materials comprise a first…
USPTO Abstract
The present invention provides porous biologically compatible materials capable of being formed into surgical implants, comprising layers of poly(tetrafluoroethylene) and elastomer, having superior compliance, strength, elasticity and suturability. The materials comprise a first layer of poly(tetrafluoroethylene), a second layer of poly(tetrafluoroethylene)/elastomer mixture, optionally a third layer of elastomer, and an optional fourth layer of a monomer fibrous elastomer matrix.
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.